CAS: 1074-89-1; 6-Methoxy-9H-Purine

该化合物是一种纯净衍生物,其特点是在纯环的6个位置上有一个甲氧基组.该化合物是有机合成和制药研究的多用途中间体,特别是在开发核循环模拟分子和生物活性分子方面.其结构特征使其对研究酶相互作用和改变核循环酸基础很有价值.甲氧基替代可增强稳定性和影响电子特性,促进选择性化学转化.6-Methoxy-9H-purine通常用于医药化学,用于抗病毒和抗癌剂设计的潜在应用.可提供高纯度的等级,以确保研究应用中的再生性.

结构式图片

相似化合物

20535-83-5 207511-17-9 17861-06-2

上下游产品

CAS号124-41-4 甲醇钠 | CAS号87-42-3 6-氯嘌呤 | CAS号19765-64-1 6-methoxypurine... | CAS号555-16-8 对硝基苯甲醛 | CAS号65-85-0 苯甲酸 | CAS号85110-40-3 9-(1-ethoxyethy... | CAS号37109-88-9 2′-Deoxy-6-O-me... | CAS号5746-29-2 Inosine, 6-O-methyl | CAS号21802-76-6 7-benzyl-6-meth... | CAS号6937-62-8 9-benzyl-6-meth... | CAS号578-76-7 7-甲基鸟嘌呤 | CAS号5746-29-2 Inosine, 6-O-methyl | CAS号38917-24-7 6-methoxy-7-met... | CAS号3324-66-1 6-methoxy-3-met...

合成工艺路线路线简述

    9-<2-Deoxy-β-D-Erythro-Pentofuranosyl>-6-Methoxy-9H-Purine 以 盐酸,水 用作溶剂,化学反应生成6-甲氧基嘌呤
    参考文献:6-取代的9-(2-脱氧-β-D-异戊-呋喃呋喃糖基)嘌呤及其9-(1-烷氧乙基)对应部分的酸性水解:动力学和机理.1个
    标题:6-取代的9-(2-脱氧-β-D-异戊-呋喃呋喃糖基)嘌呤及其9-(1-烷氧乙基)对应部分的酸性水解:动力学和机理.1个
    摘要:已经在不同浓度的氧离子下测量了几种6-取代的9-(2-脱氧-β-D-赤-戊呋喃糖基)嘌呤和9-(1-烷氧基乙基)嘌呤的水解速率常数.解释了改变烷氧基极性性质对未取代的9-(1-烷氧基乙基)嘌呤水解的影响,这表明该反应通过质子化碱部分的限速离去并伴随形成一个烷氧基乙基氧碳鎓离子.通过比较6-取代基对这些化合物及其9-(1-烷氧基乙基)反应剂的反应性的影响,将相同的机理应用于9-(2-脱氧-β-D-赤-戊呋喃糖基)嘌呤的水解.-部分.当2'-脱氧腺苷水解后进行1 H NMR光谱.
    Doi:10.1016/s0040-4020(01)90052-3

    专利信息


    专利号:US-6818633-B2
    优先权日:2001-06-29
    标题:Antiviral compounds and methods for synthesis and therapy
    发明人:BALZARINI JAN M R; DE CLERCQ ERIK D A; HOLY ANTONIN
    权利人:ACAD OF SCIENCE CZECH REPUBLIC; REGA STICHTING
    摘要:Novel compounds are provided having formula (I)whereR1, R2, R3, R4, Z, X and * are defined herein. Also provided are antiviral methods for use and processes for synthesis of the compounds of formula (I).

    专利号:US-4849513-A
    优先权日:1983-12-20
    标 题 :Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
    发明人:SMITH LLOYD M; FUNG STEVEN; KAISER ROBERT J
    权利人:CALIFORNIA INST OF TECHN
    摘要:The invention consists of compounds and methods for the synthesis of oligonucleotides which contain one or more free aliphatic amino groups attached to the sugar moieties of the nucleoside subunits. The synthetic method is versatile and general, permitting amino groups to be selectively placed at any position on oligonucleotides of any composition or length which is attainable by current DNA synthetic methods. Fluorescent dyes or other detectable moieties may be covalently attached to the amino groups to yield the corresponding modified oligonucleotide.

    专利号:US-5118802-A
    优先权日:1983-12-20
    标 题:DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
    发明人:SMITH LLOYD M; FUNG STEVEN; KAISER JR ROBERT J
    权利人:CALIFORNIA INST OF TECHN
    摘要:The invention consists of compounds and methods for the synthesis of oligonucleotides which contain one or more free aliphatic amino groups attached to the sugar moieties of the nucleoside subunits. The synthetic method is versatile and general, permitting amino groups to be selectively placed at any position on oligonucleotides of any composition or length which is attainable by current DNA synthetic methods. Fluorescent dyes or other detectable moieties may be covalently attached to the amino groups to yield the corresponding modified oligonucleotide.

    专利号:US-2012149888-A1
    优先权日:2009-02-22
    标 题:Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeuctics, diagnostics, g- tetrad forming oligonucleotides and aptamers
    发明人:SRIVASTAVA SURESH C; PANDEY DIVYA; SRIVASTAVA NAVEEN P; SRIVASTAVA ALOK
    权利人:SRIVASTAVA SURESH C; PANDEY DIVYA; SRIVASTAVA NAVEEN P; SRIVASTAVA ALOK
    摘要:The present invention relates to synthesis, purification and methods to obtain high purity novel 2′-arabino-O-methyl nucleosides and the corresponding phosphoramidites of various arabinonucleoside bases and introduction of such units into defined sequence synthetic DNA and RNA. Various synthetic oligonucleotides, such as HIV integrase inhibitor 14-mer and thrombin binding oligonucleotide, thrombin-1, bearing ara-2′-omethyl modification have been synthesized. It is anticipated the oligonucleotides incorporating these monomers will exhibit biological activities related to antisense approach approach, design of better SiRNA's, diagnostic agents. Similarly, it is anticipated that oligonucleotides incorporating such novel nucleosides will be useful to develop therapeutic candidates designing stable G-quadruplexes and Aptamers for oligonucleotide structure, folding topology, evaluation of biochemical properties and design and develop as therapeutic agents. It is further anticipated that the nucleosides, phosphates and triphosphates of this invention could develop as therapeutic agents.

    专利号:US-5118800-A
    优先权日:1983-12-20
    标 题 :Oligonucleotides possessing a primary amino group in the terminal nucleotide
    发明人:SMITH LLOYD M; FUNG STEVEN; KAISER JR ROBERT J
    权利人:CALIFORNIA INST OF TECHN
    摘要:The invention consists of compounds and methods for the synthesis of oligonucleotides which contain one or more free aliphatic amino groups attached to the sugar moieties of the nucleoside subunits. The synthetic method is versatile and general, permitting amino groups to be selectively placed at any position on oligonucleotides of any composition or length which is attainable by current DNA synthetic methods. Fluorescent dyes or other detectable moieties may be covalently attached to the amino groups to yield the corresponding modified oligonucleotide.

    专利号:US-7115592-B2
    优先权日:2003-06-16
    标题:Phosphonate substituted pyrimidine compounds and methods for therapy
    发明人:BALZARINI JAN M R; DE CLERCQ ERIK D A; HOLY ANTONIN; HOCKOVA DANA
    权利人:BIOCHEMISTRY OF THE ACADEMY OF
    摘要:Novel compounds are provided having formula (I) n nwheren n R 1 , R 2 , R 3 , R 4 , Z, X and * are defined herein. Also provided are antiviral methods for use and processes for synthesis of the compounds of formula (I).
    浙江诚意药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zjcyyy.com
    电话: 86-577-63483980 63487860 86-21-65228989👤
    📞浙江诚意药业股份有限公司 ⚠️参考联系方式

    销售电话:86-577-63483980 63487860 86-21-65228989
    邮箱:export@chengyipharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:An Efficient Synthesis Of Substituted Cytosines And Purines Under Focused Microwave Irradiation
    作者:Ling-Kuen Huang,Yen-Chih Cherng,Yann-Ru Cheng,Jing-Pei Jang,Yi-Ling Chao,Yie-Jia Cherng |发布日期:2007.6
    摘要:A Rapid Nucleophilic Displacement Reaction Of 6-Chloropurine, 2-Amino-6-Chloropurine And 5-Bromocytosine With Various Nucleophiles Under Focused Microwave Irradiation Is Described. Using This Method, The Desired Products Were Obtained With The Yields Up To 99% In A Short Reaction Time.

    合成参考文献


    摘要:Liang, Y.; Wen, Z.; Cabrera, M.; Howlader, A. H.; Wnuk, S. F., Science of Synthesis Knowledge Updates, (2020) 1, 278.
    摘要:Liang, Y.; Wen, Z.; Cabrera, M.; Howlader, A. H.; Wnuk, S. F., Science of Synthesis Knowledge Updates, (2020) 1, 298.
    摘要:Liang, Y.; Wen, Z.; Cabrera, M.; Howlader, A. H.; Wnuk, S. F., Science of Synthesis Knowledge Updates, (2020) 1, 297.
    参考文献:10.1007/s00268-002-4053-5
    摘要:Yazawa K, Fisher WE, Brunicardi FC. Current progress in suicide gene therapy for cancer. World J Surg. 2002 Jul;26(7):783–9. doi: 10.1007/s00268-002-4053-5.
    参考文献:10.1107/s010827010302314x
    摘要:Fridman N, Kapon M, Kaftory M. Two hydrates of 6-methoxypurine. Acta Crystallogr C Cryst Struct Commun. 2003 Dec 06;60(1):o44–6. doi: 10.1107/s010827010302314x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知